Adrian von Segesser
Direktor/Vorstandsmitglied bei ewl Energie Wasser Luzern Holding AG
Profil
Adrian von Segesser has worked as a Director at SpePharm AG and as a Member-Supervisory Board at ewl Energie Wasser Luzern Holding AG.
Aktive Positionen von Adrian von Segesser
| Unternehmen | Position | Beginn |
|---|---|---|
ewl Energie Wasser Luzern Holding AG
 ewl Energie Wasser Luzern Holding AG Alternative Power GenerationUtilities ewl Energie Wasser Luzern Holding AG engages in the generation and distribution of electricity. The firm’s services include electricity, gas, water, heat, telecommunications, and mobility. It also provides installation and energy consulting. The company was founded on December 18, 2000 and is headquartered in Lucerne, Switzerland. | Direktor/Vorstandsmitglied | 01.01.2010 |
SpePharm AG
 SpePharm AG Pharmaceuticals: MajorHealth Technology SpePharm AG acquires, registers, and markets medical value medicines for the hospital sector. Its brands include Dantrium IV, Dantrium, Dantamacrin, Lymphoseek and Mugard. The company was founded in 2012 and is headquartered in Luzern, Switzerland. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
ewl Energie Wasser Luzern Holding AG
ewl Energie Wasser Luzern Holding AG Alternative Power GenerationUtilities ewl Energie Wasser Luzern Holding AG engages in the generation and distribution of electricity. The firm’s services include electricity, gas, water, heat, telecommunications, and mobility. It also provides installation and energy consulting. The company was founded on December 18, 2000 and is headquartered in Lucerne, Switzerland. | Utilities |
SpePharm AG
SpePharm AG Pharmaceuticals: MajorHealth Technology SpePharm AG acquires, registers, and markets medical value medicines for the hospital sector. Its brands include Dantrium IV, Dantrium, Dantamacrin, Lymphoseek and Mugard. The company was founded in 2012 and is headquartered in Luzern, Switzerland. | Health Technology |
